|
It is more important to
know what sort of person has a disease than to
know
what sort of disease a
person has.
Predictive Technology Group, Inc.
Predictive Technology Group aims to revolutionize
patient care through predictive data
analytics, novel gene-based diagnostics and
companion therapeutics through its wholly owned
subsidiaries Predictive Therapeutics and Predictive
Biotech.
These subsidiaries are focused on endometriosis,
scoliosis, degenerative disc disease and
regenerative tissue products. The subsidiaries use
genetic and other information as cornerstones in the
development of new diagnostics that assess a
person’s risk of illness and therapeutic products
designed to identify, prevent and treat diseases
more effectively.
Additional information is
at www.predictivetechnologygroup.com,
www.predrx.com and
www.predbiotech.com.
Technical Analysis
This
biotech company has established a base at current
levels
.
We expect that the company will shortly break out
and test $1.25 resistance followed by a move to the
$1.80
.
|
